Apolipoprotein B assessment for evaluating lipid goals

Tekiner E., Oguz A. , Uzunlulu M. , Tekiner F.

ACTA CARDIOLOGICA, cilt.66, ss.433-438, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 66 Konu: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.2143/ac.66.4.2126590
  • Sayfa Sayıları: ss.433-438


Objective It is suggested that the apolipoprotein (Apo) B levels are more valuable than LDL cholesterol (LDL-C) levels in assessing cardiovascular risk associated with hyperlipidaemia. However, although non-HDL cholesterol (non-HDL-C) levels are accepted as a secondary objective after achieving LDL-C levels in the guidelines, Apo B has not been recommended as a therapeutic goal yet. The objective of this study was to determine how many of the patients who achieved the LDL-C and non-HDL-C target recommended by the guidelines with a statin therapy achieved the Apo B target.